RESULTS OF RADIOSURGICAL TREATMENT OF PATIENTS WITH METASTATIC BRAIN LESION
PDF (Русский)

Keywords

RADIOSURGERY
BRAIN METASTASES
WHOLE BRAIN IRRADIATION

How to Cite

Banov, S., Golanov, A., Vetlova, Y., Osinov, I., Kostyuchenko, V., & Ilyalov, S. (2017). RESULTS OF RADIOSURGICAL TREATMENT OF PATIENTS WITH METASTATIC BRAIN LESION. Voprosy Onkologii, 63(1), 52–61. https://doi.org/10.37469/0507-3758-2017-63-1-52-61

Abstract

Objective: To study the overall survival and intracranial relapse in patients with brain metastases (BM) after radiosurgical treatment (SRS) on the machine Gamma Knife.

Material and Methods: The analysis of treatment results in 416 patients with BM (178 men and 238 women) was conducted. Patients with radiosensitive tumors: breast cancer (n = 113; 27,1%) and non-small cell lung cancer (n = 119; 28,6%) prevailed. 222 patients (53.4%) had multiple (4 or more niduses) BM. The median of cumulative volume and the number of BM was 5,3 cm3 (0,09-56,6) and 5 (1-39), respectively. The average marginal dose of ionizing radiation was 21 Gy (range 15-24 Gy). The average time of clinical follow-up was 11,7 months (0.2-64.4 months).

Results: The overall survival of patients for 12 and 24 months was 34,5% and 20,9%, respectively. The median overall survival after SRS was 7,5 months (95% confidence interval (CI) - 5,0-9,0). The local control of BM was achieved in 88,0% of the patients. The development of new BM was reported in 37,1% of the patients. The median time without progression was 10,6 months (95% CI 8,5-18,7). KPS > 70, BM radiosensitive tumors, limited (3 or less) BM and absence of extracranial metastases are the best predictors of better survival.

Conclusions: Implementation of SRS in patients with BM provides median overall survival equal to 10.0 months. The KPS >70, BM <3 lesion, radiosensitive morphology of primary tumor and absence of extracranial metastases are predictors of better survival.

https://doi.org/10.37469/0507-3758-2017-63-1-52-61
PDF (Русский)

References

Алешин В.А., Карахан В.Б., Насхлеташвили Д.Р., Бекяшев А.Х. и др. Определение тактики лечения пациентов с метастатическим поражением головного мозга - пришло ли время для стандартов? // Опухоли головы и шеи. - 2011. - T. 2. - C. 31-34.

Голанов А.В., Банов С.М., Ветлова Е.Р. Метастатическое поражение головного мозга: изменение парадигмы лучевого лечения // Вопросы онкологии. - 2015. - T. 61. - № 4. - C. 530-545.

Голанов А.В., Банов С.М., Ильялов С.Р., Ветлова Е.Р. и др. Современные подходы к лучевому лечению метастатического поражения головного мозга // Злокачественные опухоли. - 2014. - № 3 (10). - C. 137-140.

Ильялов С.Р. Стереотаксическая радиохирургия вну-тримозговых метастазов рака с применением установки «leksell gamma knife» // Вопросы нейрохирургии им. H.H. Бурденко. - 2007. - № 3. - C. 47-53.

Канаев С.В., Гиршович М.М., Мельник Ю.С., Клинический опыт радиохирургического лечения метастатического поражения головного мозга при злокачественных новообразованиях // Вопросы онкологии. - 2016. - Т. 62. - № 2. - C. 258-264.

Куржупов. М.И., Зайцев А.М., Лошаков В.А., Филоненко Е.В. Лечение больных с метастатическим поражением головного мозга // Онкохирургия. - 2010. - Т. 2. - № 4. - C. 45-50.

Поддубная И.В. Достижения современной химиотерапии // Современная онкология. - 2013. - Т. 2. - № 5. - C. 49.

Gaspar L., Scott C., Rotman M., Asbell S. et al. Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trials // International Journal of Radiation Oncology, Biology, Physics. - 1997. - Vol. 37. - № 4. - P. 745-751.

Sperduto P.W., Berkey B., Gaspar L.E., Mehta M. et al. A New Prognostic Index and Comparison to Three Other Indices for Patients With Brain Metastases // International Journal of Radiation Oncology, Biology, Physics. - 2008. - Vol.70. - № 2. - P. 510-514.

Lippitz B., Lindquist C., Paddick I., Peterson D. et al. Stereotactic radiosurgery in the treatment of brain metastases // Cancer Treatment Reviews. - 2014. - Vol. 40. - № 1. - P. 48-59.

Yamamoto M., Serizawa T., Shuto T., Akabane A. et al. Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901) // The Lancet Oncology. - 2014. - Vol. 15. - № 4. - P. 387-395.

Andrews D. W., Scott C. B., Sperduto P. W., Flanders A.E. et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial // Lancet (London, England). - 2004. - Vol. 363. - № 9422. - P. 1665-1672.

Aoyama H., Shirato H., Tago M., Nakagawa K. et al. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial // JAMA. - 2006. - Vol. 295. - № 21. - P. 2483-2491.

Aoyama H., Tago M., Shirato H. Stereotactic Radiosurgery With or Without Whole-Brain Radiotherapy for Brain Metastases: Secondary Analysis of the JROSG 99-1 Randomized Clinical Trial // JAMA oncology. - 2015. - Vol. 1. - № 4. - P. 457-464.

Barnholtz-Sloan J.S., Sloan A.E., Davis F.G., Vigneau F.D. et al. Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System // Journal of clinical oncology: official journal of the American Society of Clinical Oncology. - 2004. - Vol. 22. - № 14. - P. 2865-2872.

Baumert B.G., Rutten I., Dehing-Oberije C., Twijnstra A., et al., A pathology-based substrate for target definition in radiosurgery of brain metastases // International journal of radiation oncology, biology, physics. - 2006. - Vol. 66. - № 1. - P. 187-194.

Cavaliere R., Schiff D., Chemotherapy and cerebral metastases: misperception or reality? // Neurosurgical focus. - 2007. - Vol. 22. - № 3. - P. E6.

Chiou S.-M. Validity of the graded prognostic assessment-derived index to predict brain-metastatic patients' survival after Gamma Knife radiosurgery // International journal of radiation oncology, biology, physics. - 2010. - Vol. 78. - № 4. - P. 1156-1162.

Golden D.W., Lamborn K.R., McDermott M.W., Kunwar S. et al. Prognostic factors and grading systems for overall survival in patients treated with radiosurgery for brain metastases: variation by primary site // Journal of neurosurgery. - 2008. - 109 Suppl. - P. 77-86.

Gondi V., Mehta M.P. Novel insights into the management of brain metastases // Current opinion in neurology. - 2010. - Vol. 23. - № 6. - P. 556-562.

Karlsson B., Hanssens P., Wolff R., Soderman M. et al. Thirty years' experience with Gamma Knife surgery for metastases to the brain // Journal of neurosurgery. - 2009. - Vol. 111. - № 3. - P. 449-457.

Khuntia D., Brown P., Li J., Mehta M. P. Whole-brain radiotherapy in the management of brain metastasis // Journal of clinical oncology: official journal of the American Society of Clinical Oncology. - 2006. - Vol. 24. - № 8. - P. 1295-1304.

Klos K.J., O'Neill B.P., Brain metastases // The neurologist. - 2004. - T. 10. № 1. C. 31-46.

Kocher M., Soffietti R., Abacioglu U., Vill S. et al. Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study // Journal of clinical oncology: official journal of the American Society of Clinical Oncology. - 2011. - Vol. 29. - № 2. - P. 134-141.

Kondziolka D., Patel A., Lunsford L.D., Kassam A. et al. Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases // International journal of radiation oncology, biology, physics. - 1999. - Vol. 45. - № 2. - P. 427-434.

Lagerwaard F.J., Levendag P.C., Nowak P.J., Eijkenboom W. M. et al. Identification of prognostic factors in patients with brain metastases: a review of 1292 patients // International journal of radiation oncology, biology, physics. - 1999. - Vol. 43. - № 4. - P. 795-803.

Langer C.J., Mehta M.P. Current management of brain metastases, with a focus on systemic options // Journal of clinical oncology: official journal of the American Society of Clinical Oncology. - 2005. - Vol. 23. - № 25. - P. 6207-6219.

Lorenzoni J., Devriendt D., Massager N., David P. et al. Radiosurgery for treatment of brain metastases: estimation of patient eligibility using three stratifications systems // International journal of radiation oncology, biology, physics. - 2004. - Vol. 60. - № 1. - P. 218-224.

Muacevic A., Wowra B., Siefert A., Tonn J.-C. et al. Microsurgery plus whole brain irradiation versus Gamma Knife surgery alone for treatment of single metastases to the brain: a randomized controlled multicentre phase III trial // Journal of neuro-oncology. - 2008. - Vol. 87. - № 3. - P. 299-307.

Paek S.H., Audu P.B., Sperling M.R., Cho J. et al. Reevaluation of surgery for the treatment of brain metastases: review of 208 patients with single or multiple brain metastases treated at one institution with modern neurosurgical techniques // Neurosurgery. - 2005. - Vol. 56. - № 5. - P. 1021.

Serizawa T., Hirai T, Nagano O., Higuchi Y. et al. Gamma knife surgery for 1-10 brain metastases without prophylactic whole-brain radiation therapy: analysis of cases meeting the Japanese prospective multi-institute study (JLGK0901) inclusion criteria // Journal of neurooncology. - 2010. - Vol. 98. - № 2. - P. 163-167.

Serizawa T., Yamamoto M., Sato Y., Higuchi Y., et al., Gamma Knife surgery as sole treatment for multiple brain metastases: 2-center retrospective review of 1508 cases meeting the inclusion criteria of the JLGK0901 multi-institutional prospective study // Journal of neurosurgery. - 2010. - 113 Suppl. - P. 48-52.

Sperduto P.W., Chao S. T., Sneed P.K., Luo X., et al., Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients // International journal of radiation oncology, biology, physics. - 2010. - Vol. 77. - № 3. - P. 655-661.

Sperduto P. W., Kased N., Roberge D., Xu Z. et al. Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases // Journal of clinical oncology: official journal of the American Society of Clinical Oncology. - 2012. - Vol. 30. - № 4. - P. 419-425.

Vogelbaum M.A., Suh J.H. Resectable brain metastases // Journal of clinical oncology: official journal of the American Society of Clinical Oncology. - 2006. - Vol. 24. - № 8. - P. 1289-1294.

Weltman E., Salvajoli J.V., Brandt R.A., Morais Hanriot R. de et al. Radiosurgery for brain metastases // International Journal of Radiation Oncology, Biology, Physics. - 2000. - Vol. 46. - № 5. - P. 1155-1161.

Yamamoto M., Kawabe T., Sato Y., Higuchi Y. et al. A case-matched study of stereotactic radiosurgery for patients with multiple brain metastases: comparing treatment results for 1-4 vs /= 5 tumors: clinical article // Journal of neurosurgery. - 2013. - Vol. 118. - № 6. - P. 1258-1268.

Yu C.P., Cheung J.Y.C., Chan J.F.K., Leung S.C.L. et al. Prolonged survival in a subgroup of patients with brain metastases treated by gamma knife surgery // Journal of neurosurgery. - 2005. - 102 Suppl. - P. 262-265.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

© АННМО «Вопросы онкологии», Copyright (c) 2017